I. Ben-Sahra
Molecular Biology · 2008–2016
A researcher in the Science corpus: 4 papers; trusts 2 researchers and is trusted by 4 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 31 citations into it; #9,512 of 17,773 by trust here, #7,574 by citations
Whom I. Ben-Sahra trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts I. Ben-Sahra overall
Papers from I. Ben-Sahra's perspective
Ordered by how strongly the researchers I. Ben-Sahra trusts endorse each paper. Same corpus, a different order for every researcher.
- Role of AMP-activated protein kinase in mechanism of metformin action. (Journal of Clinical Investigation)
- AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. (Cell Metabolism)
- Metformin and reduced risk of cancer in diabetic patients (British medical journal)
- Dimethylbiguanide Inhibits Cell Respiration via an Indirect Effect Targeted on the Respiratory Chain Complex I* (Journal of Biological Chemistry)
- Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells. (Cancer Research)
- Activation of a metabolic gene regulatory network downstream of mTOR complex 1. (Molecules and Cells)
- SREBP Activity Is Regulated by mTORC1 and Contributes to Akt-Dependent Cell Growth (Cell Metabolism)
- mTOR signaling in growth control and disease (Cell)
- The mTOR-regulated phosphoproteome reveals a mechanism of mTORC1-mediated inhibition of growth factor signaling (Science)
- Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex. (Genes & Development)
Their papers
- mTORC1 Induces Purine Synthesis Through Control of the Mitochondrial Tetrahydrofolate Cycle (2016) — 705 citations
- Stimulation of de novo pyrimidine synthesis by growth signaling through mTOR and S6K1 (2013) — 722 citations
- The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level (2008) — 880 citations
- Metformin, independent of AMPK, induces mTOR inhibition and cell-cycle arrest through REDD1. (2011) — 610 citations